Results for bleeding complication translation from English to Slovenian

wound complication
zaplet v zvezi z rano

anaesthetic complication:
zapleti pri anesteziji:

bleeding the most common complication encountered during metalyse therapy is bleeding.
krvavitev med zdravljenjem z metalysom je najpogostnejši zaplet krvavitev.

complications of myelosuppression include infections and bleeding.
zapleti mielosupresije vključujejo okužbe in krvavitve.

overdosage of desirudin could lead to bleeding complications.
preveliko odmerjanje desirudina lahko povzroči krvavitvene zaplete.

the most common complication encountered during reteplase therapy is bleeding.
najpogostejši zaplet, na katerega naletimo med zdravljenjem z reteplazo, je krvavitev.

should a bleeding complication arise in a patient receiving edoxaban, the next edoxaban administration should be delayed or treatment should be discontinued as appropriate.
Če se pri bolniku, ki prejema edoksaban, pojavi krvavitev, je treba naslednji odmerek edoksabana odložiti ali prekiniti zdravljenje, kot je ustrezno.

overdose of efient may lead to prolonged bleeding time and subsequent bleeding complications.
preveliko odmerjanje zdravila efient lahko vodi v podaljšan čas krvavitve in nadaljnje zaplete zaradi krvavitve.

overdose following clopidogrel administration may lead to prolonged bleeding time and subsequent bleeding complications.
preveliki odmerki klopidogrela lahko podaljšajo čas krvavitve in posledično povzročijo zaplete s krvavitvijo.

elderly: patients of advanced age have an increased risk of bleeding complications with anticoagulation.
starostniki: pri starejših bolnikih je tveganje zapletov s krvavitvami zaradi antikoagulacijske terapije večje.

in the event of haemorrhagic complications, treatment must be discontinued and the source of bleeding investigated.
pri zapletih zaradi krvavitve moramo zdravljenje prekiniti in ugotoviti njen izvor.

clopidogrel: overdose following clopidogrel administration may lead to prolonged bleeding time and subsequent bleeding complications.
klopidogrel: preveliki odmerki klopidogrela lahko podaljšajo čas krvavitve in posledično povzročijo zaplete s krvavitvijo.

19 bleeding minor bleeding was a very common (> 1/ 10) complication of eptifibatide administration (13.1% eptifibatide vs 7.6% placebo).
19 krvavitve manjše krvavitve so bile zelo pogosti (> 1/ 10) zaplet uporabe eptifibatida (13, 1% za eptifibatid, 7, 6% za placebo).

overdose with asa/ clopidogrel fixed dose combination may be associated with increased bleeding and subsequent bleeding complications due to the pharmacological activity of clopidogrel and asa.
preveliko odmerjanje fiksne kombinacije acetilsalicilne kisline/klopidogrela lahko spremljajo večja nagnjenost h krvavitvam in posledični krvavitveni zapleti; to je posledica farmakološkega delovanja klopidogrela in acetilsalicilne kisline.

data in adult humans are conflicting, and there has been no increase in bleeding complications in randomised controlled trials in term and near-term neonates with hypoxic respiratory failure.
podatki pri odraslih ljudeh so si nasprotujoči, pri randomiziranih nadzorovanih kliničnih preizkušanjih na novorojenčkih s hipoksično respiratorno odpovedjo, rojenih v roku ali blizu roka, pa ni bilo povečanja zapletov pri krvavitvah.

anticoagulant activity should be monitored in patients taking warfarin or other anticoagulants, particularly in the first few days after initiating or changing the dose of celecoxib, since these patients have an increased risk of bleeding complications.
te bolnike namreč bolj ogrožajo zapleti s krvavitvami.

4.5 interaction with other medicinal products and other forms of interaction pharmacodynamic interactions anticoagulant activity should be monitored particularly in the first few days after initiating or changing the dose of celecoxib in patients receiving warfarin or other anticoagulants since these patients have an increased risk of bleeding complications.
te bolnike namrec bolj ogrožajo zapleti s krvavitvami.

when desirudin is administered in patients with increased risk of bleeding complications, mild to moderate hepatic dysfunction and/or mild to moderate renal impairment, aptt should be monitored and peak aptt should not exceed twice the control value.
med uporabo desirudina pri bolnikih z zvečanim tveganjem za krvavitvene zaplete, blago do zmerno disfunkcijo jeter in/ali blago do zmerno okvaro ledvic je treba nadzirati aptČ; najvišji aptČ ne sme preseči dvakratne kontrolne vrednosti.

other gastrointestinal disease without active ulceration that can potentially lead to bleeding complications (e.g. inflammatory bowel disease, oesophagitis, gastritis and gastroesophageal reflux disease)
druge bolezni prebavil, brez aktivne razjede, ki lahko privedejo do zapletov s krvavitvami (npr. vnetna črevesna bolezen, ezofagitis, gastritis in gastroezofagealna refluksna bolezen),

complications
poškodbe in zastrupitve